These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3877825)

  • 1. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
    Niiya K; Hirose S; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of F.IX-inhibitor bypassing activity contained in a commercial prothrombin complex concentrate (Proplex)].
    Sugimoto M; Fujimura Y; Okubo Y; Takahashi Y; Yoshioka A; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1984 Aug; 47(5):1181-9. PubMed ID: 6516702
    [No Abstract]   [Full Text] [Related]  

  • 3. [The successful use of FEIBA for treatment of intracranial hemorrhage in a patient of hemophilia B with inhibitor].
    Taki M; Inagaki M; Tomita Y; Miura T; Saito N; Meguro T; Yamada K
    Rinsho Ketsueki; 1985 Aug; 26(8):1300-5. PubMed ID: 3877831
    [No Abstract]   [Full Text] [Related]  

  • 4. Prothrombin complex concentrates: preparation, properties, and clinical uses.
    White GC; Lundblad RL; Kingdon HS
    Curr Top Hematol; 1979; 2():203-44. PubMed ID: 318075
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-inhibitor coagulant complex (Autoplex) in hemophilia inhibitor patients undergoing synovectomy.
    Hutchinson RJ; Penner JA; Hensinger RN
    Pediatrics; 1983 Apr; 71(4):631-3. PubMed ID: 6601258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor.
    Mizon P; Goudemand J; Jude B; Marey A
    Ann Hematol; 1992 Jun; 64(6):309-11. PubMed ID: 1637888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity.
    Negrier C; Goudemand J; Sultan Y; Bertrand M; Rothschild C; Lauroua P
    Thromb Haemost; 1997 Jun; 77(6):1113-9. PubMed ID: 9241742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening sublingual hematoma in a severely hemophilic patient with factor VIII inhibitor.
    Takeuchi M; Shikimori M; Kaneda T
    J Oral Maxillofac Surg; 1986 May; 44(5):401-3. PubMed ID: 3084733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
    Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
    N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hemophiliacs with inhibitors].
    Fujimaki M
    Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
    [No Abstract]   [Full Text] [Related]  

  • 12. Activated factor IX complex in treatment of surgical cases of hemophilia A with inhibitors.
    Hanna WT; Madigan RR; Miles MA; Lange RD
    Thromb Haemost; 1981 Oct; 46(3):638-41. PubMed ID: 6976016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS; Johnson FF; Robinson JA; Aggeler PM
    N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
    [No Abstract]   [Full Text] [Related]  

  • 14. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience.
    Tjønnfjord GE
    Haemophilia; 2004 Sep; 10 Suppl 2():41-5. PubMed ID: 15385045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin complex concentrates: clinical use.
    Menache D
    Ann N Y Acad Sci; 1981; 370():747-56. PubMed ID: 6791551
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
    Diniz MJ; Dias Francisco F; Tavares ML; Leal I
    Acta Med Port; 1992 Apr; 5(4):178-80. PubMed ID: 1605065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [6-years' experience with the clinical use of the hemostatic preparation, PPSB].
    Koniukhov SG; Saltykova ZA; Tarasova LN
    Probl Gematol Pereliv Krovi; 1977 Aug; 22(8):37-40. PubMed ID: 928338
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgery in haemophilic patients with inhibitors.
    Rodriguez-Merchan EC
    Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
    [No Abstract]   [Full Text] [Related]  

  • 19. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery.
    Santagostino E; Mannucci PM; Gringeri A; Tagariello G; Baudo F; Bauer KA; Rosenberg RD
    Thromb Haemost; 1994 Jun; 71(6):737-40. PubMed ID: 7974341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC.
    Philippou H; Adami A; Lane DA; MacGregor IR; Tuddenham EG; Lowe GD; Rumley A; Ludlam CA
    Thromb Haemost; 1996 Jul; 76(1):23-8. PubMed ID: 8819246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.